FDA Guidance for Industry: Possible Dioxin/PCB Contamination of Drug and Biological Products

Titel:
FDA Guidance for Industry: Possible Dioxin/PCB Contamination of Drug and Biological Products
Herkunft/Verlag:

FDA, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070310.pdf

Inhalt:
Mögliche Dioxinbelastung von pharmazeutischen Einsatzmaterialien

Zurück

GMP Seminare nach Thema